SwePub
Sök i LIBRIS databas

  Extended search

L773:1876 2891
 

Search: L773:1876 2891 > (2010-2014) > Probiotic and synbi...

Probiotic and synbiotic safety in infants under two years of age

van den Nieuwboer, M (author)
Athena Inst, Vrije Univ Amsterdam, Amsterdam, Netherlands; Swammerdam Inst Life Sci, Univ Amsterdam, Amsterdam, Netherlands
Claassen, E (author)
Athena Inst, Vrije Univ Amsterdam, Amsterdam, Netherlands; Dept Virosci, Erasmus MC, Rotterdam, Netherlands
Morelli, L (author)
Ist Microbiol, Univ Cattolica SC, Piacenza, Italy
show more...
Guarner, F (author)
CIBERehd, Digest Syst Res Unit, Univ Hosp Vall dHebron, Barcelona, Spain
Brummer, Robert J, 1957- (author)
Örebro universitet,Institutionen för läkarutbildning,Region Örebro län
show less...
 (creator_code:org_t)
Wageningen : Wageningen Academic Publishers, 2014
2014
English.
In: Beneficial Microbes. - Wageningen : Wageningen Academic Publishers. - 1876-2883 .- 1876-2891. ; 5:1, s. 45-60
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • In this study, we systematically evaluated safety aspects in clinical trials with probiotics and synbiotics in young infants (0-2 years of age). This study is an update of earlier reports and covers the recent literature from 2008-2013. The safety evaluation is performed along the Common Terminology Clinical Adverse Events (CTCAE) version 4.0 scale, hereby also providing guidance for future studies. Safety aspects are represented and related to number of participants per probiotic strain/culture, study duration, dosage, clinical condition and selected afflictions. The results show a deficiency in the precise reporting and classification of adverse events in most studies. Analysis of 57 clinical trials with probiotics and synbiotics in combination with eight follow-up studies indicate that probiotic administration to infants between 0 and 24 months is safe with regard to the evaluated strains in infants with a particular health status or susceptibility. Most adverse events and serious adverse events were considered unrelated to the study product, and there were no major safety concerns. Almost all studies concluded that none of the adverse effects were related to the study product; the study products are generally well tolerated. Finally, inconsistent, imprecise and potentially incomplete reporting as well as the variation in probiotic strains, dosages, administration regimes, study populations and reported outcomes, greatly limit the generalizability of conclusions and argue convincingly for obligatory and standardised behaviour on adverse events (CTCAE) reporting in 'food' studies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Näringslära (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Nutrition and Dietetics (hsv//eng)

Keyword

prebiotics; probiotics; health benefits; food safety legislation; children

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
van den Nieuwboe ...
Claassen, E
Morelli, L
Guarner, F
Brummer, Robert ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Microbiology in ...
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Health Sciences
and Nutrition and Di ...
Articles in the publication
Beneficial Micro ...
By the university
Örebro University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view